USD 7.79
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.04 Billion | 6.57 Billion | 25.35 Billion | 24.29 Billion | 41.91 Billion | 13.96 Billion |
Net Income | 17.34 Billion | 24.94 Billion | 30.49 Billion | 25.2 Billion | 37.51 Billion | 49.17 Billion |
Depreciation & Amortization | 1.92 Billion | 2.04 Billion | 3.51 Billion | 3.44 Billion | 2.19 Billion | 1.77 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -14.59 Billion | -7.45 Billion | 781 Million | 2.33 Billion | 9.18 Billion | -12.99 Billion |
Other non-cash items | 16.19 Billion | -12.96 Billion | -9.43 Billion | -6.68 Billion | -6.96 Billion | -23.98 Billion |
Investing Cash Flow | -7.79 Billion | 47.46 Billion | -3.77 Billion | -7.26 Billion | -14.84 Billion | -805 Million |
Investments in PPE | -2.4 Billion | -2.46 Billion | -3.18 Billion | -1.32 Billion | -4.22 Billion | -5.03 Billion |
Acquisitions | 2.33 Billion | 2.6 Billion | 726 Million | -87 Million | -25.6 Billion | -1.92 Billion |
Investment purchases | -3.92 Billion | -436 Million | -1.55 Billion | -125 Million | -16 Million | -10.53 Billion |
Sales/Maturities of investments | 947 Million | 5.53 Billion | 71 Million | 276 Million | 1.78 Billion | 721 Million |
Other Investing Activities | -4.59 Billion | 42.22 Billion | 179 Million | -6 Billion | 13.22 Billion | 15.96 Billion |
Financing Cash Flow | -9.16 Billion | -58.46 Billion | -17.8 Billion | -19.38 Billion | -22.74 Billion | -11.75 Billion |
Debt repayment | -1.46 Billion | -71.29 Billion | -33.27 Billion | -15.31 Billion | -13.46 Billion | -21.17 Billion |
Dividends payments | -8.17 Billion | -8.08 Billion | -6.88 Billion | -7.09 Billion | -7.2 Billion | -6.47 Billion |
Common Stock Repurchased | -1.96 Billion | -2.47 Billion | -19.54 Billion | -11.67 Billion | - | -232 Million |
Common Stock Issuance | -6 Million | 24.13 Billion | 40.86 Billion | - | - | 17.22 Billion |
Other Financing Activities | -154 Million | -761 Million | 1.03 Billion | 3.02 Billion | -2.07 Billion | -1.1 Billion |
Accounts receivables | -277 Million | 458 Million | 5.77 Billion | -4.8 Billion | 5.9 Billion | -3.35 Billion |
Accounts payables | -15.53 Billion | 14.31 Billion | 4.95 Billion | -2.09 Billion | 1.21 Billion | 80 Million |
Inventory | -150 Million | -14.3 Billion | -5.33 Billion | 3.67 Billion | 21.03 Billion | -9.79 Billion |
Other working capital | 1.36 Billion | -7.92 Billion | -4.62 Billion | 5.55 Billion | -18.97 Billion | -3.2 Billion |
Cash at beginning of period | 57.4 Billion | 62.56 Billion | 58.21 Billion | 59.44 Billion | 55.41 Billion | 54.36 Billion |
Cash at end of period | 41.44 Billion | 56.65 Billion | 62.56 Billion | 58.21 Billion | 59.44 Billion | 55.41 Billion |
Capital Expenditure | -2.4 Billion | -2.46 Billion | -3.18 Billion | -1.32 Billion | -4.22 Billion | -5.03 Billion |
Effect of forex changes on cash | -39 Million | -1.48 Billion | 573 Million | 1.12 Billion | -302 Million | -357 Million |
Net cash flow / Change in cash | -15.95 Billion | -5.91 Billion | 4.35 Billion | -1.22 Billion | 4.02 Billion | 1.04 Billion |
Free Cash Flow | -1.35 Billion | 4.11 Billion | 22.17 Billion | 22.97 Billion | 37.69 Billion | 8.93 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 4.37 Billion | 4.37 Billion | 7 Billion | 17.34 Billion | 3.57 Billion | 10.33 Billion |
Depreciation & Amortization | 469 Million | 469 Million | 972 Million | 1.92 Billion | 486 Million | 955 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -70.5 Million | -14.59 Billion | -70.5 Million | - |
Other non-cash items | -4.1 Billion | -4.1 Billion | -1.35 Billion | 16.19 Billion | -1.98 Billion | -13.01 Billion |
Investing Cash Flow | -1.63 Billion | -1.63 Billion | -8.05 Billion | -7.79 Billion | -2.14 Billion | 259 Million |
Investments in PPE | - | - | -1.2 Billion | -2.4 Billion | -1.2 Billion | - |
Acquisitions | - | - | 2.33 Billion | 2.33 Billion | -2.29 Billion | - |
Investment purchases | -1.4 Billion | - | -3.28 Billion | -3.92 Billion | - | -641 Million |
Sales/Maturities of investments | - | - | 947 Million | 947 Million | - | - |
Other Investing Activities | -1.63 Billion | -1.63 Billion | -5.49 Billion | -4.59 Billion | 1.35 Billion | 900 Million |
Financing Cash Flow | -3.78 Billion | -3.78 Billion | 330 Million | -9.16 Billion | -1.24 Billion | -9.49 Billion |
Debt repayment | -1.52 Billion | - | -1.6 Billion | -1.46 Billion | - | -142 Million |
Dividends payments | -2.84 Billion | -2.84 Billion | -1.52 Billion | -8.17 Billion | -906.5 Million | -6.64 Billion |
Common Stock Repurchased | -771.5 Million | -771.5 Million | -708 Million | -1.96 Billion | -354 Million | -1.26 Billion |
Common Stock Issuance | - | - | -6 Million | -6 Million | - | - |
Other Financing Activities | -166.5 Million | -166.5 Million | 1.29 Billion | -154 Million | 14.5 Million | -1.45 Billion |
Accounts receivables | - | - | -9 Million | -277 Million | -9 Million | - |
Accounts payables | - | - | - | -15.53 Billion | - | - |
Inventory | - | - | -75 Million | -150 Million | -75 Million | - |
Other working capital | - | - | 13.5 Million | 1.36 Billion | 13.5 Million | - |
Cash at beginning of period | 41.44 Billion | - | 43.82 Billion | 57.4 Billion | - | 57.4 Billion |
Cash at end of period | 31.8 Billion | -4.78 Billion | 41.44 Billion | 41.44 Billion | -1.26 Billion | 43.82 Billion |
Capital Expenditure | - | - | -1.2 Billion | -2.4 Billion | -1.2 Billion | - |
Effect of forex changes on cash | -102.5 Million | -102.5 Million | 114 Million | -39 Million | 114 Million | -133.5 Million |
Net cash flow / Change in cash | -9.64 Billion | -4.78 Billion | -2.37 Billion | -15.95 Billion | -1.26 Billion | -13.58 Billion |
Free Cash Flow | 735.5 Million | 735.5 Million | 3.47 Billion | -1.35 Billion | 804.5 Million | -3.63 Billion |
CRNT
PSO
CSLI
600084
2645
603678